Erk 1/2 and survivin could contribute to imatinib resistance in CML cell line independent of Bcr-Abl

Thumbnail Image

Files

Daniela final.pdf (1.68 MB)

Date

2016

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

INCA

Abstract

Description

Keywords

Citation

URI

http://sr-vmlxaph03:8080/jspui/handle/123456789/4730

Collections

Pôsteres publicados pela Área de Edição e Produção de Materiais Técnico-científicos

Endorsement

Review

Supplemented By

Referenced By